Cargando…

Positive feedback regulation between IL10 and EGFR promotes lung cancer formation

The role of IL10 in the tumorigenesis of various cancer types is still controversial. Here, we found that increased IL10 levels are correlated with a poor prognosis in lung cancer patients. Moreover, IL10 levels were significantly increased in the lungs and serum of EGFR(L858R)- and Kras4b(G12D)-ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Tsung-I, Wang, Yi-Chang, Hung, Chia-Yang, Yu, Chun-Hui, Su, Wu-Chou, Chang, Wen-Chang, Hung, Jan-Jong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991496/ https://www.ncbi.nlm.nih.gov/pubmed/26956044 http://dx.doi.org/10.18632/oncotarget.7894

Ejemplares similares

Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression
por: Lin, Ching-Chan, et al.
Publicado: (2020)

USP24 induces IL-6 in tumor-associated microenvironment by stabilizing p300 and β-TrCP and promotes cancer malignancy
por: Wang, Yi-Chang, et al.
Publicado: (2018)

An IL-17-EGFR-TRAF4 axis contributes to the alleviation of lung inflammation in severe influenza
por: Dutta, Avijit, et al.
Publicado: (2023)

EGFR Tyrosine Kinase Inhibitor Efficacy in Older Adult Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer: A Meta-Analysis and Systematic Review
por: Chen, Chang-Hung, et al.
Publicado: (2022)

Sustaining the Activation of EGFR Signal by Inflammatory Cytokine IL17A Prompts Cell Proliferation and EGFR-TKI Resistance in Lung Cancer
por: Lee, Kai-Ling, et al.
Publicado: (2023)

Sp1-mediated microRNA-182 expression regulates lung cancer progression
por: Yang, Wen-Bin, et al.
Publicado: (2014)

Targeting EGFR and Monitoring Tumorigenesis of Human Lung Cancer Cells In Vitro and In Vivo Using Nanodiamond-Conjugated Specific EGFR Antibody
por: Lin, Yu-Wei, et al.
Publicado: (2022)

Is there an association between nurse, clinical teacher and peer feedback for trainee doctors’ medical specialty choice? An observational study in Taiwan
por: Hsu, Chih-Ming, et al.
Publicado: (2018)

Association of IL10, IL10RA, and IL10RB Polymorphisms with Benign Prostate Hyperplasia in Korean Population
por: Yoo, Koo Han, et al.
Publicado: (2011)

Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells
por: Yao, Yongxue, et al.
Publicado: (2005)

Elevated BCRP/ABCG2 Expression Confers Acquired Resistance to Gefitinib in Wild-Type EGFR-Expressing Cells
por: Chen, Yun-Ju, et al.
Publicado: (2011)

IL‐10 from plasmacytoid dendritic cells promotes angiogenesis in the early stage of endometriosis
por: Suen, Jau‐Ling, et al.
Publicado: (2019)

Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer
por: Su, Po-Lan, et al.
Publicado: (2018)

Positive end-expiratory pressure attenuates positional effect after thoracotomy
por: Lan, Chou-Chin, et al.
Publicado: (2014)

Discovery and characterization of a monoclonal antibody targeting a conformational epitope of IL-6/IL-6Rα to inhibit IL-6/ IL-6Rα/gp130 hexameric signaling complex formation
por: Chou, Chun-Chi, et al.
Publicado: (2022)

Nm23-H1-stabilized hnRNPA2/B1 promotes internal ribosomal entry site (IRES)-mediated translation of Sp1 in the lung cancer progression
por: Hung, Chia-Yang, et al.
Publicado: (2017)

A novel derivative of betulinic acid, SYK023, suppresses lung cancer growth and malignancy
por: Hsu, Tsung-I, et al.
Publicado: (2015)

The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung Adenocarcinoma
por: Huang, Yen-Hsiang, et al.
Publicado: (2022)

Correction: A novel derivative of betulinic acid, SYK023, suppresses lung cancer growth and malignancy
por: Hsu, Tsung-I, et al.
Publicado: (2019)

Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance
por: Chang, Kwang-Yu, et al.
Publicado: (2013)

IL-31 Associated with Coronary Artery Lesion Formation in Kawasaki Disease
por: Tseng, Wan-Ning, et al.
Publicado: (2014)

Obesity alters ovarian folliculogenesis through disrupted angiogenesis from increased IL-10 production
por: Yang, Po-Kai, et al.
Publicado: (2021)

Impaired dendritic cell maturation and IL-10 production following H. pylori stimulation in gastric cancer patients
por: Chang, Lin-Li, et al.
Publicado: (2012)

Implication of the IL-10-Expression Signature in the Pathogenicity of Leptospira-Infected Macrophages
por: Chou, Li-Fang, et al.
Publicado: (2022)

Simvastatin Inhibits IL-5-Induced Chemotaxis and CCR3 Expression of HL-60-Derived and Human Primary Eosinophils
por: Fu, Chia-Hsiang, et al.
Publicado: (2016)

Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinoma
por: Su, Kang-Yi, et al.
Publicado: (2018)

N‐glycosylated GPNMB ligand independently activates mutated EGFR signaling and promotes metastasis in NSCLC
por: Han, Chia‐Li, et al.
Publicado: (2021)

Mitochondrial phosphoenolpyruvate carboxykinase promotes tumor growth in estrogen receptor‐positive breast cancer via regulation of the mTOR pathway
por: Hsu, Hui‐Ping, et al.
Publicado: (2022)

Importance of early detection of infantile inflammatory bowel disease with defective IL-10 pathway: A case report
por: Hung, Hua-Hsi, et al.
Publicado: (2021)

Mitochondrial translocation of EGFR regulates mitochondria dynamics and promotes metastasis in NSCLC
por: Che, Ting-Fang, et al.
Publicado: (2015)

Positive Feedback Promotes Oscillations in Negative Feedback Loops
por: Ananthasubramaniam, Bharath, et al.
Publicado: (2014)

Positive feedback and synchronized bursts in neuronal cultures
por: Huang, Yu-Ting, et al.
Publicado: (2017)

Human FBXL8 Is a Novel E3 Ligase Which Promotes BRCA Metastasis by Stimulating Pro-Tumorigenic Cytokines and Inhibiting Tumor Suppressors
por: Chang, Shu-Chun, et al.
Publicado: (2020)

Differential Impact of IL-10 Expression on Survival and Relapse between HPV16-Positive and -Negative Oral Squamous Cell Carcinomas
por: Chuang, Chun-Yi, et al.
Publicado: (2012)

Dynamic changes in quality of life after three first-line therapies for EGFR mutation-positive advanced non-small-cell lung cancer
por: Yang, Szu-Chun, et al.
Publicado: (2018)

Improved survival in patients with unresectable stage III EGFR ‐mutant adenocarcinoma with upfront EGFR‐tyrosine kinase inhibitors
por: Wang, Sheng‐Yuan, et al.
Publicado: (2021)

Irradiation Suppresses IFNγ-Mediated PD-L1 and MCL1 Expression in EGFR-Positive Lung Cancer to Augment CD8(+) T Cells Cytotoxicity
por: Wang, Chun-I., et al.
Publicado: (2021)

The safety and adequacy of resection on hepatocellular carcinoma larger than 10 cm: A retrospective study over 10 years
por: Chen, Jian-Han, et al.
Publicado: (2015)

Effect of S‐1 on survival outcomes in 838 patients with advanced pancreatic cancer: A 7‐year multicenter observational cohort study in Taiwan
por: Lai, Hsiang‐Lan, et al.
Publicado: (2019)

Do patient characteristics affect EGFR tyrosine kinase inhibitor treatment outcomes? A network meta‐analysis of real‐world survival outcomes of East Asian patients with advanced non‐small cell lung cancer treated with first‐line EGFR‐TKIs
por: Chang, Huang‐Chih, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_72hum02p9uq94vms59uluujh1i